ABCG2 and hyperuricemia: Its variants can lead to destabilization of the nucleotide-binding structural domain of ABCG2, resulting in its reduced expression and dysfunction, leading to the inadequate renal excretion of urate, causing hyperuricemia and gout (Wong et al., 2016).